「MicroGen」 completa una ronda de financiación de 300 millones de yuanes en la Serie A+, y lanza conjuntamente una plataforma abierta de colaboración en cálculo biológico con IA

robot
Generación de resúmenes en curso

Deep Tide TechFlow news, March 30, according to 36Kr reports, the synthetic biology R&D company Weiyuan Synthesis completed a 300 million yuan Series A+ financing in March 2026, with investments from Henan Investment Group HuiRong Fund and Mr. Tan Ruiqing. This round of funding will be used to expand the boundaries of AI biological computing applications, increase investment in core technology R&D, and promote scenario-based implementation.

Meanwhile, Weiyuan Synthesis, in collaboration with Stanford University, Princeton University, Peking University, ByteDance, NVIDIA, and other institutions, launched the open collaboration platform PoseX at ICLR 2026, aiming to solve the molecular docking challenges in real-world scenarios, and conducted systematic evaluations of 24 mainstream methods. The test results show that top AI docking methods (such as SurfDock) and co-folding methods (such as AlphaFold3) have fully surpassed traditional physical models in accuracy and robustness for cross-conformation docking tasks.

Currently, Weiyuan Synthesis has completed the research and industrialization of multiple products including altronose, lutein, and mannitol, and is accelerating the development of product pipelines related to methanol biomanufacturing.

Ver originales
Esta página puede contener contenido de terceros, que se proporciona únicamente con fines informativos (sin garantías ni declaraciones) y no debe considerarse como un respaldo por parte de Gate a las opiniones expresadas ni como asesoramiento financiero o profesional. Consulte el Descargo de responsabilidad para obtener más detalles.
  • Recompensa
  • Comentar
  • Republicar
  • Compartir
Comentar
Añadir un comentario
Añadir un comentario
Sin comentarios
  • Anclado